Alexion Spikes on Q2 Earnings Blowout Providing Positive Signs for Rest of Sector

Shares of Alexion Pharmaceuticals Inc. (ALXN) rose 6.7% to $139.88 in premarket trading on Thursday, July 27, after the New Haven, Conn.-based firm unveiled second-quarter results.